A2ML1 and esophageal squamous cell carcinoma: Compared to the control group, the tumors derived from A2ML1 overexpression ESCC cells were smaller and the growth rate was lower (Figure 3(a), P < 0.0001; 3(b), P < 0.01; 3(c)).